![]() Theravance Biopharma Theravance Biopharma is a biopharmaceutical company which provides medicines to treat serious illnesses. | ![]() Inflazome Inflazome engages in developing orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the inflammasome. | ![]() Prothena Prothena is a global biotechnology company seeking to fundamentally alter the course of progressive diseases. | ![]() Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines. | ||
Founding Date | Founding Date 1996 | Founding Date 2003 | Founding Date 2016 | Founding Date 2012 | Founding Date 1976 |
Type | Type Public | Type Subsidiary | Type Subsidiary | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Dublin, IE HQ San Francisco, US | Locations Cambridge, US HQ Zug, CH | Locations Dublin 2, IE HQ Brisbane City, AU Cambridge, GB | Locations Dublin, IE HQ South San Francisco, US | Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more |
Employees | Employees 97 | Employees 636% decrease | Employees 156% decrease | Employees 163 | Employees 18,077 |
Valuation ($) | Valuation ($) 429 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 983.1 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $107.5m (FY, 2025) | Revenue (est.) $92.5m (FY, 2020) | Revenue (est.) N/A | Revenue (est.) $9.7m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income $105.9m (FY, 2025) | Net income ($166m) (FY, 2020) | Net income N/A | Net income ($244.1m) (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 55m | Total funding raised $ 141.8m | Total funding raised $ 17m | Total funding raised N/A | Total funding raised N/A |

Acceleron Pharma is a clinical-stage biopharmaceutical company.
View company
Inflazome engages in developing orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the inflammasome.
View company
Prothena is a global biotechnology company seeking to fundamentally alter the course of progressive diseases.
View company
Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.
View company